Acta Psychiatrica Scandinavica

Combination of antidepressants and psychological treatments for bulimia nervosa: a systematic review
pp. 256-264(9)
Authors: Bacaltchuk, J.; Trefiglio, R. P.; Oliveira, I. R.; Hay, P.; Lima, M. S.; Mari, J. J.

Cognitive impairment and syndromal depression in estimates ofactive life expectancy: the 13‐year follow‐up of the Baltimore Epidemiologic Catchment Area sample
pp. 265-273(9)
Authors: Gallo, Joseph J.; Schoen, Robert; Jones, Richard

Cognitive dysfunctions and white matter lesions in patients with bipolardisorder in remission
pp. 274-280(7)
Authors: Krabbendam, L.; Honig, A.; Wiersma, J.; Vuurman, E. F. P. M.; Hofman, P. A. M.; Derix, M. M. A.; Nolen, W. A.; Jolles, J.

Cognitive dysfunction in obsessive‐compulsive disorder
pp. 281-285(5)
Authors: Okasha, A.; Rafaat, M.; Mahallawy, N.; Nahas, J.; Seif El Dawla, A.; Sayed, M.; El Kholi, S.

Sex differences in late‐life depression
pp. 286-292(7)
Authors: Sonnenberg, C. M.; Beekman, A. T. F.; Deeg, D. J. H.; van Tilburg, W.

Regional differences in schizophrenia incidence in Denmark
pp. 293-299(7)
Authors: Schelin, E. M.; Munk‐Jørgensen, P.; Olesen, A. V.; Gerlach, J.

Changes in negative symptoms and the risk of tardive dyskinesia:a longitudinal study
pp. 300-306(7)
Authors: van Os, J.; Walsh, E.; van Horn, E.; Tattan, T.; Bale, R.; Thompson, S. G.

Quantitative EEG in `positive' and `negative' schizophrenia
pp. 307-311(5)
Authors: Begić, D.; Hotujac, Lj.; Jokić‐Begić, N.

Heterogeneity in schizophrenia; mixture modelling of age‐at‐first‐admission, gender and diagnosis
pp. 312-317(6)
Authors: Welham, J.; McLachlan, G.; Davies, G.; McGrath, J.

Effects of a coping‐orientated group therapy for schizophrenia and schizoaffective patients: a pilot study
pp. 318-322(5)
Authors: Andres, K.; Pfammatter, M.; Garst, F.; Teschner, C.; Brenner, H. D.

Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning
pp. 323-329(7)
Authors: Morosini, P.‐L.; Magliano, L.; Brambilla, L.; Ugolini, S.; Pioli, R.

Patient satisfaction: a valid index of quality of care in a psychiatric service
pp. 330-333(4)
Authors: Shipley, K.; Hilborn, B.; Hansell, A.; Tyrer, J.; Tyrer, P.

Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation
pp. 334-336(3)
Authors: Raskin, S.; Katz, G.; Zislin, Z.; Knobler, H. Y.; Durst, R.

Biography
pp. 337-337(1)
Author: Tansella, Michele

Progressive brain atrophy and VBR increase in schizophrenia?
pp. 338-339(2)
Authors: Garver MD., David L.; Nair MD, Thamilarasi R; Christensen PhD, Jaines D.

Progressive brain atrophy and VBR increase in schizophrenia?
pp. 338-339(2)
Authors: Garver MD., D.L.; Nair MD, T.R.; Christensen PhD, J.D.

Progressive brain atrophy and VBR increase in schizophrenia? with Reply: A.Madsen
pp. 338-339(2)
Authors: Garver MD., D.L.; Nair MD, T.R.; Christensen PhD, J.D.

Errata
pp. 339-339(1)

Errata
pp. 339-339(1)

Books received (selected titles)
pp. 340-340(1)